Concepedia

Erin Sult

ES

9

Publications

1.1K

Citations

9

H-Index

2014

Active since

Affiliations

AstraZeneca (United States)(Current)

The University of Queensland

Juntendo University

QIMR Berghofer Medical Research Institute

Erin Sult is an author at AstraZeneca (United States) specializing in medicine, tumor immunity, and tumor biology.

Top concepts

Publications per year

2014–2022

9

Publications

9

Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses

Arabella Young, Shin Foong Ngiow, Deborah S. Barkauskas et al. · Cancer Cell · 2016 · 373 citations · Full text

, , +11

A New Bliss Independence Model to Analyze Drug Combination Data

Wei Zhao, Kris F. Sachsenmeier, Lanju Zhang et al. · SLAS DISCOVERY · 2014 · 308 citations · Full text

Targeting CD73 in the tumor microenvironment with MEDI9447

Carl Hay, Erin Sult, Qihui Huang et al. · OncoImmunology · 2016 · 281 citations · Full text

Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium

Charles E. Birse, Robert Lagier, William W. Fitzhugh et al. · Clinical Proteomics · 2015 · 40 citations · Full text

Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases

Dipti Vijayan, Deborah S. Barkauskas, Kimberley Stannard et al. · OncoImmunology · 2017 · 28 citations · Full text

Rows per page

1–5 of 9